BioMarin to Report Q4 Earnings: Here's What to Expect

Published on 17 Feb 2025 on Zacks · via Yahoo Finance

Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of...

Read the rest of the article

Start tracking your investments with Statfolio

King & Spalding partner Jamieson Greer reported earning more than $1.467 million from his work wi...

Law.com 19 Feb 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 17 Feb 2025

Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise...

Zacks · via Yahoo Finance 17 Feb 2025

However, the growth potential is expected to have been partially offset by lower Kuvan sales. BMR...

Zacks · via Yahoo Finance 17 Feb 2025

The FDA approves AXSM's Symbravo for the acute treatment of migraine with or without aura in adul...

Zacks · via Yahoo Finance 1 Feb 2025

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid...

Zacks · via Yahoo Finance 31 Jan 2025

BioMarin Pharmaceutical (BMRN) San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the...

Zacks · via Yahoo Finance 31 Jan 2025

The FDA accepts and grants priority review to Merck's sNDA for Welireg to treat advanced...

Zacks · via Yahoo Finance 28 Jan 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with t...

Zacks · via Yahoo Finance 28 Jan 2025

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we ar...

Insider Monkey · via Yahoo Finance 28 Jan 2025